Gerstein Fisher’s Bristol-Myers Squibb BMY Stock Holding History

Gerstein Fisher’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$762K	Sell	14,138 -517	-4%	-$33.2K	0.09%	189
2016 Q2	$1.08M	Buy	14,655 +1,843	+14%	+$130K	0.14%	136
2016 Q1	$818K	Buy	12,812 +445	+4%	+$28.1K	0.11%	156
2015 Q4	$851K	Buy	12,367 +1,620	+15%	+$107K	0.12%	157
2015 Q3	$636K	Sell	10,747 -47	-0.4%	-$2.98K	0.1%	189
2015 Q2	$718K	Buy	10,794 +3,045	+39%	+$201K	0.12%	176
2015 Q1	$500K	Sell	7,749 -114	-1%	-$7.14K	0.08%	230
2014 Q4	$464K	Buy	7,863 +27	+0.3%	+$1.52K	0.08%	235
2014 Q3	$401K	Buy	7,836 +1,388	+22%	+$69.3K	0.07%	241
2014 Q2	$313K	Buy	6,448 +269	+4%	+$13.3K	0.06%	250
2014 Q1	$321K	Sell	6,179 -20,755	-77%	-$1.1M	0.06%	236
2013 Q4	$1.43M	Buy	26,934 +14,381	+115%	+$733K	0.05%	244
2013 Q3	$581K	Buy	12,553 +229	+2%	+$10.1K	0.13%	151
2013 Q2	$551K	Buy	+12,324	New	+$535K	0.13%	138

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Gerstein Fisher's BMY Position: Q3 2016 in Review

Gerstein Fisher reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q3 2016, selling an estimated $33.2K and leaving 14,138 shares worth $762K. The position accounts for 0.09% of the portfolio, ranked #189.

Gerstein Fisher first reported a position in BMY in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.43M in Q4 2013. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Gerstein Fisher held 14,138 shares of Bristol-Myers Squibb worth $762K as of Q3 2016.
Gerstein Fisher sold 517 Bristol-Myers Squibb shares in Q3 2016, an estimated $33.2K.
Bristol-Myers Squibb made up 0.09% of Gerstein Fisher's portfolio in Q3 2016, its #189 holding.
Gerstein Fisher first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 14 quarters since.
Gerstein Fisher's Bristol-Myers Squibb position peaked at $1.43M in Q4 2013.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.